| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.41 | 0.02 |